147 related articles for article (PubMed ID: 20172052)
1. Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines.
Akhlaghi SP; Saremi S; Ostad SN; Dinarvand R; Atyabi F
Nanomedicine; 2010 Oct; 6(5):689-97. PubMed ID: 20172052
[TBL] [Abstract][Full Text] [Related]
2. Multimeric System of RGD-Grafted PMMA-Nanoparticles as a Targeted Drug- Delivery System for Paclitaxel.
Gibbens-Bandala BV; Ocampo-García BE; Ferro-Flores G; Morales-Avila E; Ancira-Cortez A; Jaimes-Aguirre L
Curr Pharm Des; 2017; 23(23):3415-3422. PubMed ID: 28403791
[TBL] [Abstract][Full Text] [Related]
3. Curcuminoid-loaded poly(methyl methacrylate) nanoparticles for cancer therapy.
Sahu A; Solanki P; Mitra S
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):101-105. PubMed ID: 29593406
[TBL] [Abstract][Full Text] [Related]
4. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
[TBL] [Abstract][Full Text] [Related]
5. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
[TBL] [Abstract][Full Text] [Related]
6. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation.
Yu J; Liu Y; Zhang L; Zhao J; Ren J; Zhang L; Jin Y
J Biomater Sci Polym Ed; 2015; 26(18):1475-89. PubMed ID: 26489688
[TBL] [Abstract][Full Text] [Related]
7. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation.
Saremi S; Atyabi F; Akhlaghi SP; Ostad SN; Dinarvand R
Int J Nanomedicine; 2011 Jan; 6():119-28. PubMed ID: 21289989
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
Lv W; Cheng L; Li B
Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
12. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
Pandey V; Gajbhiye KR; Soni V
Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
[TBL] [Abstract][Full Text] [Related]
14. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
15. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of chitosan-grafted-polycaprolactone micelles for modulate intestinal paclitaxel delivery.
Almeida A; Silva D; Gonçalves V; Sarmento B
Drug Deliv Transl Res; 2018 Apr; 8(2):387-397. PubMed ID: 28116655
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
19. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
[TBL] [Abstract][Full Text] [Related]
20. Development of polymeric nanopaclitaxel and comparison with free paclitaxel for effects on cell proliferation of MCF-7 and B16F0 carcinoma cells.
Yadav D; Anwar MF; Garg V; Kardam H; Beg MN; Suri S; Gaur S; Asif M
Asian Pac J Cancer Prev; 2014; 15(5):2335-40. PubMed ID: 24716980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
